Dr. Alan Dunn, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3252 Route 35 N, Lavallette, NJ 08735 Phone: 732-830-9333 |
News Archive
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
HealthPort, an industry leader in health information technology announced today, the availability of a comprehensive software and services solution to manage audits in healthcare, including RAC, MIC, MAC and other government contractors as well as commercial plan and internal coding and compliance audits.
Affymetrix, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its CytoScan Dx Assay. This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoScan Dx Assay is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations. High resolution analysis can reveal small aberrations not readily seen using traditional techniques.
Male mice born with a genetic mutation that's believed to make humans more susceptible to schizophrenia develop behaviors that mimic other major psychiatric illnesses when their mothers are exposed to an assault to the immune system while pregnant, according to new Johns Hopkins research.
Department of Environmental Protection Secretary John Hanger today reminded Pennsylvania's citizens that although the number of West Nile Virus cases has dropped, the threat still exists.
› Verified 8 days ago